Story at a glance Some autism-linked syndromes are associated with seizures. Researchers are testing a new drug that may help reduce the frequency of convulsive and drop seizures. The experimental drug will need to go through larger clinical trials to test for efficacy. A new drug candidate shows promise in reducing seizures in children with epilepsey linked to autism, according to a study published in Epilepsia. The drug, called soticlestat, has completed phase 2 clinical trials, and now needs to go through phase 3 trials before approval for use. The drug was tested in children who have Dravet syndrome (DS) or Lennox–Gastaut syndrome (LGS), which are
Hence then, the article about new drug shows promise for autism linked syndromes was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( New drug shows promise for autism-linked syndromes )